WEDNESDAY, Dec. 14, 2022 (HealthDay News) — Bees, in their role as master pollinators, increase crop yields, leading to more production of healthy fruits, vegetables and nuts. But new research claims that the challenges these important insects face from changes in land use, harmful pesticides and climate change is affectingContinue Reading
TUESDAY, Nov. 15, 2022 (HealthDay News) – Singer Roberta Flack has the incurable disease ALS and can’t sing, but she plans to stay active on other projects, her manager said Monday. Flack, 85, is a Grammy winner best known for hits that include “Killing Me Softly With His Song” andContinue Reading
THURSDAY, Oct. 20, 2022 (HealthDay News) — Researchers have made early progress toward a new approach to treating the deadly brain disease amyotrophic lateral sclerosis (ALS): using patients’ own immune system T cells. ALS is a rare condition that kills nerve cells in the brain and spinal cord that controlContinue Reading
FRIDAY, Sept. 30, 2022 (HealthDay News) – The U.S. Food and Drug Administration on Thursday gave its approval to a new drug for ALS (amyotrophic lateral sclerosis), also known as Lou Gehrig’s disease. But approval of the drug, called Relyvrio, is bound to stir new questions, with some doubting theContinue Reading
MONDAY, Sept. 26, 2022 (HealthDay News) — People who work in manufacturing, welding and chemical operations and are exposed to hazardous chemicals may face a higher risk of developing amyotrophic lateral sclerosis (ALS), a new study found. “This study shows that certain occupational settings and exposures increase one’s chances ofContinue Reading
FRIDAY, Sept. 23, 2022 (HealthDay News) — People with a rare genetic form of ALS may benefit from extended use of an investigational drug, a new study shows. The medication, tofersen, benefited patients with mutations of the gene SOD1. These mutations create a misfolded version of a protein, which leadsContinue Reading
THURSDAY, Sept. 8, 2022 (HealthDay News) – In a rare second review, a U.S. Food and Drug Administration panel on Wednesday recommended approval for an experimental drug for ALS (amyotrophic lateral sclerosis). The FDA is not obligated to follow its advisors’ recommendations, though it usually does. Wednesday’s vote was 7-2Continue Reading
WEDNESDAY, Sept. 7, 2022 (HealthDay News) — Patients suspected of having amyotrophic lateral sclerosis (ALS) may soon be able to get a diagnosis much more quickly, not wasting the precious time many have left, new research suggests. In 2020, a blood test for ALS based on microRNA (short segments ofContinue Reading
TUESDAY, Sept. 6, 2022 (HealthDay News) – A U.S. Food and Drug Administration panel will once again consider approval for an experimental drug for ALS, a rare second review for a disease that has no cure. The same panel that will meet Wednesday voted last March not to approve theContinue Reading
TUESDAY, Aug. 9, 2022 (HealthDay News) — Flooding, heat waves and drought have made 58% of infectious diseases worse, a new analysis claims. For the review of previous studies, published Aug. 8 in the journal Nature Climate Change, researchers found that 218 of the known 375 infectious diseases have beenContinue Reading